Safer Disinfectant Use - Navigating the Landscape of COVID-19 Transmission and Exposure Reduction

This webinar was originally presented on November 3, 2021. Dr. Marwa Zaatari, PhD, Partner at D ZINE Partners and a member of the ASHRAE Epidemic Task Force, will provide the science of COVID-19 transmission and guidance recommendations for reducing airborne infectious aerosol exposure. She will discuss multiple layer defense strategies and debunk myths regarding ventilation, filtration, air cleaning, as well as physical barriers

Learning Objectives:

By the end of this webinar, participants will be able to:

• Support the science behind COVID-19 airborne transmission
• Apply updated ASHRAE recommendations to reduce risk of aerosol exposure
• Differentiate between proven and unproven technologies to reduce exposure risk 

Speakers

Marwa Zaatari, PhD, Partner, D ZINE Partners; Board Member, U.S. Green Building Council; Course Instructor, American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), Member, ASHRAE Epidemic Task Force  

Dr. Marwa Zaatari is Chief Science Officer at Blue Box Air. She leads the research of “Air as a Service” around heat exchanger coils, filters, and IAQ measurements to design and operate buildings for optimal energy and people efficiency. Dr. Zaatari has extensive experience in identifying and quantifying the sources, fate, and transport of indoor air pollutants, building energy and environmental management, assessing performance-based procedures of HVAC ventilation and air cleaning, and developing and applying models for energy efficiency, indoor air quality, exposure assessment, and economic impacts of indoor air pollution.

Prior to joining Blue Box Air, Dr. Zaatari was Vice President of Building Solutions at enVerid Systems since 2015. She lead design of ventilation and filtration/sorption systems in buildings, integration into HVAC systems, and was responsible for managing customer-site installation and ongoing operations and field service. Dr. Zaatari is an ASHRAE Distinguished Lecturer, a member of the ASHRAE Epidemic Task Force Commercial team and a member of several ASHRAE Committees, voting member of Standard 62.1, Chair for TRG4 Indoor Air Quality Procedure, Vice Chair of MTG.HWBE Health and Wellness in the built environment, Vice Chair of TC2.3 gaseous removal contaminants, Voting Member Standard 145.2 laboratory test method for gas-phase air cleaning systems, IAQ2020 Conference organizer, LEED Committee member, and ex-Chair of LEED IAQP Working Group.

Moderator:

Marissa Hauptman, MD, MPH, FAAP, Pediatrician, Children's Hospital Primary Care Center; Associate Director, Boston Children's Hospital Pediatric Environmental Health Center; Assistant Director, Region 1 New England Pediatric Environmental Health Specialty Unit; Boston Children’s Hospital; Instructor in Pediatrics, Harvard Medical School, Boston, MA

Marissa Hauptman, MD, MPH is a board certified pediatrician and a pediatric environmental health specialist at the Region 1 New England Pediatric Environmental Health Specialty Unit in the Division of General Pediatrics at Boston Children’s Hospital. She earned both a Bachelor of Science degree in Applied Mathematics/Biology and a Master of Public Health (MPH) degree in Social and Environmental Epidemiology at Brown University in Providence, Rhode Island. She earned her Medical Degree at New York University School of Medicine.  She completed her pediatrics residency in the Urban Health and Advocacy Track at the Boston Combined Residency Program in Pediatrics at Boston Children’s Hospital and Boston Medical Center. 

Dr. Hauptman’s research focuses on using spatial analysis techniques to research and improve environmental and social health disparities in urban children. Dr. Hauptman is currently engaged in a research project evaluating the impact of spatial and environmental exposures on asthma morbidity as part of the NIH funded School- Inner City Asthma Study, led by principal investigator, Dr. Wanda Phipatanakul.  She has been awarded the 2015 Academic Pediatric Association Research Award for Best Abstract by a Fellow for her research abstract entitled “Residential and School Proximity To Major Roadways and Asthma Morbidity in the School Inner-City Asthma Study” that was presented at the Pediatric Academic Societies (PAS) Annual Meeting in 2015.She has also been awarded the American Academy of Pediatrics Section on Allergy and Immunology Outstanding Abstract Award at the 2016 American Academy of Allergy, Asthma and Immunology Annual Meeting, which recognized significant research efforts in the field of asthma, allergy or immunology in children.

Dr. Hauptman has served on the Medical Review Panel for Lead Poisoning for the Massachusetts Department of Health, Bureau of Environmental Health in partnership with the Pediatric Environmental Health Center at Boston Children’s Hospital. Dr. Hauptman has also served as a commissioner on the Rhode Island Attorney General’s Advisory Commission on Lead Paint from 2005 to 2007. She was awarded a 2007 Rhode Island Healthy Housing Award by the Childhood Lead Poisoning Prevention Program of the Rhode Island Department of Health for her efforts in the development of strategies that promote healthy environments for children and families in the State of Rhode Island.

CE Origination date: November 3, 2021
CE Expiration date: December 7, 2023

ACCREDITATION STATEMENTS:

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and Pediatric Environmental Health Specialty Unit (PEHSU). The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE:  The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0.

Continuing Competency credits available are 1.0. CDC provider number 98614.

For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.

Disclosure: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use. CDC, our planners, our presenters, content experts and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planning committee reviewed content to ensure there is no bias. Presentation will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC did not accept commercial support for this continuing education activity.

Disclaimer: This course was supported by the American Academy of Pediatrics (AAP) and funded (in part) by a cooperative agreement with the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry (CDC/ATSDR). The U.S. Environmental Protection Agency (EPA) supports the PEHSUs by providing partial funding to CDC/ATSDR through an Inter-Agency Agreement. The findings and conclusions presented have not been formally disseminated by CDC/ATSDR or EPA and should not be construed to represent any agency determination or policy. Use of trade names that may be mentioned is for identification only and does not imply endorsement by the CDC/ATSDR or EPA.

WD4423-110321